These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3720527)

  • 1. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 May; 17(1):1-13. PubMed ID: 3720527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative assay of nefopam, morphine and d-amphetamine.
    Jasinski DR; Preston KL
    Psychopharmacology (Berl); 1987; 91(3):273-8. PubMed ID: 3104949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of dezocine for morphine-like subjective effects and miosis.
    Jasinski DR; Preston KL
    Clin Pharmacol Ther; 1985 Nov; 38(5):544-8. PubMed ID: 2865027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ; Henningfield JE
    Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users.
    Webster LR; Johnson FK; Stauffer J; Setnik B; Ciric S
    Drugs R D; 2011 Sep; 11(3):259-75. PubMed ID: 21902287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans.
    Vaupel DB; Lange WR; London ED
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1386-94. PubMed ID: 8263800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion: clinical assay for amphetamine-like abuse potential.
    Griffith JD; Carranza J; Griffith C; Miller LL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):206-8. PubMed ID: 6406459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pharmacology and abuse potential of meptazinol.
    Johnson RE; Jasinski DR
    Clin Pharmacol Ther; 1987 Apr; 41(4):426-33. PubMed ID: 3829579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.
    Brauer LH; De Wit H
    Pharmacol Biochem Behav; 1997 Feb; 56(2):265-72. PubMed ID: 9050084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effects of morphine and d-amphetamine on the threshold for brain stimulation reward.
    Hubner CB; Bain GT; Kornetsky C
    Pharmacol Biochem Behav; 1987 Oct; 28(2):311-5. PubMed ID: 3685064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenously administered methadone, morphine and heroin.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 Jul; 17(4):301-10. PubMed ID: 3757766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.
    Jasinski DR; Krishnan S
    J Psychopharmacol; 2009 Jun; 23(4):410-8. PubMed ID: 18635707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweet taste liking is associated with subjective response to amphetamine in women but not men.
    Weafer J; Lyon N; Hedeker D; de Wit H
    Psychopharmacology (Berl); 2017 Nov; 234(21):3185-3194. PubMed ID: 28762072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of morphine analgesia by d-amphetamine.
    Sasson S; Unterwald EM; Kornetsky C
    Psychopharmacology (Berl); 1986; 90(2):163-5. PubMed ID: 3097695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.